电邮这篇文章 Iloprost - ingalyatsionnyy analog prostatsiklina dlya lecheniya bol'nykh legochnoy gipertenziey
- 作者: Martynyuk TV1, Chazova IE1
-
隶属关系:
- 期: 卷 8, 编号 4 (2011)
- 页面: 57-63
- 栏目: Articles
- URL: https://journals.eco-vector.com/2075-082X/article/view/33163
- DOI: https://doi.org/10.26442/SG33163
- ID: 33163
如何引用文章
全文:
详细
参考
- Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the ECS and ERS, endorsed by the ISHLT. Eur Heart J 2009; 30: 2493-537.
- Gomberg-Maitland M, Olschewski H. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 2008; 31(4): 881-901.
- McLaughlin et al. Survival in primary pulmonary hypertension. The impaсt of epoprostenol therapy. Circulanion 2002; 106: 1477-82.
- Higenbottam T, Wheeldon D, Wells et al. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet 1984; 1: 1046-7.
- Barst RJ, Rubin LJ et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334: 296-301.
- Sitbon O, Humbert M et al. Long-term intravenous epoprostenol infusion in privary pulmonari hypertension: prognostic factors and survival. J Am Coll Cardiol 2002; 40: 780-8.
- Olschewski H, Ghofrani HA et al. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group. Ann Intern Med 2000; 132: 435-43.
- Olschewski H, Walmrath D, Schermuly R et al. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 1996; 124: 820-4.
- Olschewski H, Simonneau G, Galie N et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002; 347: 322-9.
- Olschewski H, Hoeper MM, Behr J et al. Long-term therapy with inhaled iloprost in patients with pulmonary hypertension. Respir Med 2010; 104: 731-40.
- McLaughlin V, Oudiz R, Frost A. Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2006; 174: 1257-63.
补充文件
